Anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines elicit lower humoral responses in solid-organ transplant recipients. This is the first prospective trial investigating the effect of an inactivated whole-virion vaccine in kidney transplant recipients.

Matéria original

Anterior

VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares

Próxima

ABIFINA participa do lançamento do Plano Nacional de Combate à Pirataria

ABIFINA participa do lançamento do Plano Nacional de Combate à Pirataria